Johnson & Johnson Cash Flow from Operating Activities 2010-2024 | JNJ
Johnson & Johnson annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Johnson & Johnson cash flow from operating activities for the quarter ending December 31, 2024 was $24.266B, a 6.47% increase year-over-year.
- Johnson & Johnson cash flow from operating activities for the twelve months ending December 31, 2024 was $54.496B, a 12.56% increase year-over-year.
- Johnson & Johnson annual cash flow from operating activities for 2024 was $24.266B, a 6.47% increase from 2023.
- Johnson & Johnson annual cash flow from operating activities for 2023 was $22.791B, a 7.54% increase from 2022.
- Johnson & Johnson annual cash flow from operating activities for 2022 was $21.194B, a 9.47% decline from 2021.
Johnson & Johnson Annual Cash Flow Ops
(Millions of US $) |
| 2024 |
$24,266 |
| 2023 |
$22,791 |
| 2022 |
$21,194 |
| 2021 |
$23,410 |
| 2020 |
$23,536 |
| 2019 |
$23,416 |
| 2018 |
$22,201 |
| 2017 |
$21,056 |
| 2016 |
$18,767 |
| 2015 |
$19,569 |
| 2014 |
$18,710 |
| 2013 |
$17,414 |
| 2012 |
$15,396 |
| 2011 |
$14,298 |
| 2010 |
$16,385 |
| 2009 |
$16,571 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$394.223B |
$88.821B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
